Connecticut EGID Specialized Formula Insurance Coverage Act
Transparency & Verification
Verified from Official SourcePolicy Pantry collects information from official and trusted public sources. Legislative information can change quickly. Always review the linked official government source for the most current details.
AI Plain-Language Summary
Click "Generate" to create an AI-powered plain-language summary of this legislation.
Summary
Requires insurance policies to cover medically necessary specialized formulas for people with eosinophilic gastrointestinal disorders up to age 26.
Full Description
Expands health insurance coverage of specialized formula for individuals with EGIDs including EoE up to age 26.
Key Provisions
Requires insurance coverage for specialized EGID formulas. Covers individuals up to age 26. Medical necessity required.
Who This Bill Serves & Who's Backing It
Core Patient Populations
Patients with eosinophilic esophagitis (EoE).
Advocacy Groups Backing This Legislation
No advocacy organizations are currently tracked as backing this bill.Browse advocacy organizations →
Legislative Timeline
Votes & Legislative History
An Act Concerning the Availability of Epinephrine in Schools
Requires local and regional boards of education to maintain a supply of epinephrine auto-injectors for use in schools.
New York Asthma Inhaler Coverage Act (S.3100A)
Provides for coverage for the treatment of asthma (wider insurance coverage of asthma medications)
S.3100A expands New York insurance coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children. New Yorkers with asthma can face large financial barriers to drugs that hinder optimal treatment; high out-of-pocket costs hinder adherence, threaten patient health, and exacerbate health disparities. The bill passed the Senate 59-2 on March 17, 2025 and was reported and committed to the Finance Committee on May 12, 2026.
An Act Concerning the Storage and Administration of Epinephrine
Authorizes schools to maintain a supply of epinephrine auto-injectors for use in emergencies and provides liability protection for school personnel.
While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.